- Location
ONE DOSE
"-
NASDAQ: ISIS Provided an Update on Its Ongoing Open Label, Multiple Dose Phase 2 Study
Feb 27, 2014Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA). To date, all four infants in the 6 mg cohort have been ...
Tags: ISIS, SMA, Infant, respiratory assistance
-
Doctors Have a Vital Role in Increasing The Number of Girls and Young Women
Feb 10, 2014MONDAY Jan.27,2014,2014--Doctors have a vital role in increasing the number of girls and young women who get a vaccine that helps protect them against cervical cancer,according to a new study. Despite calls by experts for universal human ...
Tags: Hpv Vaccination, HPV, Medicine
-
CHMP Adopted a Positive Opinion on FINOX Biotech's MAA for BEMFOLA
Feb 7, 2014The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on FINOX Biotech's marketing authorisation application (MAA) for BEMFOLA (follitropin alfa solution for injection in ...
-
Patients with Advanced Pancreatic Cancer May Live a Little Longer
Jan 16, 2014Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
Tags: a
-
Patients with Advanced Pancreatic Cancer May Live a Little Longer
Jan 16, 2014Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
-
FDA Warns Consumers Some Over-The-Counter Laxatives May Be Dangerous
Jan 10, 2014The U.S. Food and Drug Administration warns consumers some over-the-counter laxatives may be dangerous if dosing instructions or warnings are not followed. There have been dozens of reports of serious side effects, including 13 deaths, ...
-
Cerenis Therapeutics Did Not Reach Its Primary Endpoint in Post-ACS Patients
Jan 3, 2014Cerenis Therapeutics, the biopharmaceutical company, today announced that its Phase IIb CHI-SQUARE (Can HDL Infusions Significantly Quicken Atherosclerosis REgression) study did not reach its primary endpoint in post-Acute Coronary Syndrome ...
Tags: Cerenis Therapeutics, Phase IIb CHI-SQUARE, post-Acute Coronary Syndrome
-
FDA Has Approved Sovaldi 400mg Tablets
Dec 10, 2013Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...
Tags: Gilead Sciences, Chronic Hepatitis
-
It's Amazing How Coconut Oil Has Recently Been Acknowledged for The Healthy Oil
Nov 21, 2013It's amazing how coconut oil has recently been acknowledged for the healthy oil that it is after having been vilified for decades as a heart attack oil. Now it's been discovered to boost even brain health. Defaming coconut oil saturated ...
Tags: dose, coconut oil, tremendously, brain function, cognitive, performance
-
ViiV Has Announced The FDA Approval of an Integrase Inhibitor,Tivicay 50mg Tablets
Aug 15, 2013ViiV Healthcare, HIV company established by GlaxoSmithKline and Pfizer, has announced the FDA approval of an integrase inhibitor, Tivicay (dolutegravir) 50mg tablets, for the treatment of HIV-1. Tivicay is indicated for use in combination ...
Tags: Viiv Healthcare, HIV-1
-
Essential Edibles Plan to Provide Nine Hours of Herbal Energy with a Single Serving
Jan 23, 2013US-based Essential Edibles has launched a natural energy supplement, which is designed to provide nine hours of herbal energy with a single serving. The fat-free and sugar-free supplement comes in a simple capsule form and has no ...
-
The Sanofi Vaccines Division Sanofi Pasteur Has Launched JE Vaccine
Dec 11, 2012The Sanofi vaccines division Sanofi Pasteur has launched Japanese encephalitis (JE) vaccine, IMOJEV, in Australia. Australian Health Authorities approved the live-attenuated JE vaccine for people aged 12 months and older, based on data ...
Tags: Australian Health Authorities, Japanese encephalitis, vaccine, JE vaccine
-
Watson Laboratories Gained FDA ANDA Approval for Next Choice ONE DOSE
Dec 5, 2012Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has gained FDA abbreviated new drug application (ANDA) approval for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5mg). The Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5mg) ...
Tags: ONE DOSE, levonorgestrel tablet, Watson Pharmaceuticals
-
AIDAC to The US FDA Has Recommended The Use of Novartis's TIP
Nov 29, 2012The Anti-Infective Drugs Advisory Committee (AIDAC) to the US Food and Drug Administration (FDA) has recommended the use of Novartis's tobramycin inhalation powder (TIP) to treat cystic fibrosis (CF) patients whose lungs contain bacteria ...
-
Sidel Showcases Its New Packaging Solutions at Expopack 2012 From 26-29 June 2012
Nov 27, 2012Sidel, a France-based company that deals with liquid packaging and a division of Tetra Laval Group, is to showcase its new packaging solutions at ExpoPack 2012 from 26-29 June 2012 in Mexico. Sidel offers a variety of bottle designs and ...
Tags: Sidel, New Packaging Solutions
Related Products
-
Factory Price New Arrivals IoT Laundry Dispenser Detergent Dose for One Washing Machine
-
One-Stop Tablet/Capsule Production Machine for Solid Dose Pharmaceuticals
-
Folding Extrusion Liquid Filling Machine One Dose Card Type Honey Packing Machine
-
Easy Snap Sachet Liquid Packaging Machine Single Dose Honey Packaging
-
Easy Snap Sachet Honey Single Dose Pack Film Forming Filling Sealing Machine
-
Honey Handwashing Fluid Easy Snap Sachet Single Dose Filling Sealing Packing Machine
